prostate, dutasteride
Showing 1 - 25 of 5,700
Prostatic Hyperplasia, Prostate Cancer Trial in Turku (Prostate hyperplasia medication, LhRH-antagonist)
Recruiting
- Prostatic Hyperplasia
- Prostate Cancer
- Prostate hyperplasia medication
- LhRH-antagonist
-
Turku, Finland
- +1 more
Aug 17, 2023
Prostatic Tumors, Low Grade Prostate Cancer Trial in Quebec (Dietary intervention first, Drug (Dutasteride) intervention first)
Active, not recruiting
- Prostatic Neoplasms
- Low Grade Prostate Cancer
- Dietary intervention first
- Drug (Dutasteride) intervention first
-
Quebec, Canada
- +1 more
Mar 14, 2022
Prostate Cancer Trial in Rochester (Enzalutamide and Dutasteride)
Active, not recruiting
- Prostate Cancer
- Enzalutamide and Dutasteride
-
Rochester, New YorkUniversity of Rochester
Nov 2, 2021
Disease Control and Quality of Life in Benign PROStatic
Recruiting
- Benign Prostatic Hyperplasia
- Patients with Benign Prostate Hyperplasia
-
Athens, GreeceLaikon Hospital of Athens
Jul 12, 2022
Prostate Cancer Trial in Chicago (Bicalutamide, Dutasteride, Finasteride)
Active, not recruiting
- Prostate Cancer
- Bicalutamide
- +3 more
-
Chicago, IllinoisUniversity of Chicago
Sep 30, 2021
Benign Prostate Hyperplasia, Healthy Trial in Jeonju (DKF-313, AVODART, CIALIS)
Completed
- Benign Prostate Hyperplasia
- Healthy
- DKF-313
- +2 more
-
Jeonju, Jeollabuk-do, Korea, Republic ofChonbuk National University Hospital
Jul 1, 2021
Dutasteride on Architectural and Nuclear Morphometric Features
Completed
- Benign Prostate Tissue
-
Chicago, IllinoisUniversity of Illinois at Chicago
Oct 1, 2020
Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
Completed
- Prostate Cancer
- Dutasteride
- Placebo
-
Chicago, IllinoisUniversity of Illinois at Chicago
Oct 9, 2020
Benign Prostatic Hyperplasia Trial in Seoul (DKF-313, Dutasteride, Tadalafil)
Recruiting
- Benign Prostatic Hyperplasia
- DKF-313
- +5 more
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 9, 2021
Dutasteride, Category IIIB Chronic Prostatitis Trial in Cairo (Dutasteride 0.5 mg, Placebo)
Completed
- Dutasteride
- Category IIIB Chronic Prostatitis
- Dutasteride 0.5 mg
- Placebo
-
Cairo, EgyptUrology department - ain shams university
Feb 11, 2021
Prostate Specific Antigens, Prostate Tumors Trial run by the National Cancer Institute (NCI) (TARP peptide vaccine, TARP
Completed
- Prostate Specific Antigens
- Prostate Neoplasms
- T-cell receptor alternate reading frame protein (TARP) peptide vaccine
- T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 15, 2022
Prostatic Hyperplasia, Benign, Metabolic Syndrome Trial in A Coruña (Caloric Restriction, Control)
Withdrawn
- Prostatic Hyperplasia, Benign
- Metabolic Syndrome
- Caloric Restriction
- Control
-
A Coruña, SpainJose Luis Ponce Diaz-Reixa
Jul 26, 2021
Benign Prostatic Hyperplasia, Prostate Hyperplasia, Prostate Disease Trial in Boston (Finasteride)
Recruiting
- Benign Prostatic Hyperplasia
- +7 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 26, 2022
Prostate Hyperplasia Trial in Hong Kong (3D-Ultrasound-Guided Transperineal Microwave needle ablation of BPH)
Not yet recruiting
- Prostate Hyperplasia
- 3D-Ultrasound-Guided Transperineal Microwave needle ablation of BPH
-
Hong Kong, Hong KongPrince of Wales Hospital
Jun 30, 2022
Androgenic Alopecia Trial in São José dos Campos (MESOTHERAPY (INJECTIONS WITH SYRINGE AND NEEDLE), MMP (INJECTIONS WITH A
Recruiting
- Androgenic Alopecia
- MESOTHERAPY (INJECTIONS WITH SYRINGE AND NEEDLE)
- MMP (INJECTIONS WITH A TATTOO MACHINE)
-
São José dos Campos, São Paulo, BrazilClinica Dermatologica Arbache
Oct 30, 2023
Alcohol Use Disorder Trial in Farmington (Dutasteride Capsules, Placebo Capsules)
Recruiting
- Alcohol Use Disorder
- Dutasteride Capsules
- Placebo Capsules
-
Farmington, ConnecticutUniversity of Connecticut Health Center
Jun 14, 2022
Amyotrophic Lateral Sclerosis Trial in Valencia (dietary supplement, other, drug)
Recruiting
- Amyotrophic Lateral Sclerosis
- Liposomed polyphenols resveratrol and curcumin
- +4 more
-
Valencia, SpainJosé Enrique de la Rubia Ortí
Aug 3, 2022
Prostatic Hyperplasia, Prostate Hyperplasia, Prostatic Hypertrophy Trial in Seoul (alpha-blocker or 5-ARI withdrawal,
Recruiting
- Prostatic Hyperplasia
- +2 more
- alpha-blocker or 5-ARI withdrawal
- Maintenance of alpha-blocker and 5-ARI
-
Seoul, Korea, Republic ofGangnam Severance Hospital, Yonsei University College of Medicin
Aug 21, 2021
Prostate Cancer Trial in Boston (ketoconazole, hydrocortisone, dutasteride)
Salivary Duct Carcinoma Trial in Nijmegen (Goserelin 10.8 mg, Bicalutamide 50 mg, Dutasteride 0.5 mg)
Not yet recruiting
- Salivary Duct Carcinoma
- Goserelin 10.8 mg
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Aug 23, 2022
Prostate Cancer Trial in Boston (Precision screening intervention, Usual care)
Not yet recruiting
- Prostate Cancer
- Precision screening intervention
- Usual care
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jun 21, 2023
Prostate Adenocarcinoma Trial in United States (procedure, drug, dietary supplement)
Not yet recruiting
- Prostate Adenocarcinoma
- Biopsy
- +3 more
-
Los Angeles, California
- +4 more
Sep 7, 2023
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Istanbul (Performing cognitive prostate biopsy with a
Recruiting
- Prostate Cancer
- +4 more
- Performing cognitive prostate biopsy with a radiologist's guidance with map
- Performing cognitive prostate biopsy without a radiologist's guidance with map
-
Istanbul, TurkeyMarmara University, School of Medicine, Department of Urology
Jun 5, 2023